

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GDP-mannose metabolic process (GO:0019673) | 5.99743779 |
| 2 | proline biosynthetic process (GO:0006561) | 4.86759129 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 4.56789261 |
| 4 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21046856 |
| 5 | protein carboxylation (GO:0018214) | 4.21046856 |
| 6 | urea cycle (GO:0000050) | 4.13762352 |
| 7 | mannose metabolic process (GO:0006013) | 4.00414169 |
| 8 | protein retention in ER lumen (GO:0006621) | 3.92950949 |
| 9 | urea metabolic process (GO:0019627) | 3.88516021 |
| 10 | UV protection (GO:0009650) | 3.83833209 |
| 11 | proline metabolic process (GO:0006560) | 3.83177439 |
| 12 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.75156498 |
| 13 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.72003780 |
| 14 | negative regulation of cell size (GO:0045792) | 3.63118541 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 3.60330965 |
| 16 | NADH metabolic process (GO:0006734) | 3.57298160 |
| 17 | adenosine receptor signaling pathway (GO:0001973) | 3.56898007 |
| 18 | endothelial cell chemotaxis (GO:0035767) | 3.54370144 |
| 19 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.53692704 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45365545 |
| 21 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.44645014 |
| 22 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.43293209 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.38138698 |
| 24 | semaphorin-plexin signaling pathway (GO:0071526) | 3.37372530 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 3.36053243 |
| 26 | protein insertion into membrane (GO:0051205) | 3.33881811 |
| 27 | cell-cell junction maintenance (GO:0045217) | 3.33820847 |
| 28 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.31358172 |
| 29 | apoptotic process involved in morphogenesis (GO:0060561) | 3.25588419 |
| 30 | regulation of early endosome to late endosome transport (GO:2000641) | 3.15839359 |
| 31 | regulation of cholesterol metabolic process (GO:0090181) | 3.12708457 |
| 32 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.11655158 |
| 33 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.09620191 |
| 34 | negative regulation of fatty acid transport (GO:2000192) | 3.02136241 |
| 35 | epithelial cell-cell adhesion (GO:0090136) | 3.01580276 |
| 36 | protein localization to endosome (GO:0036010) | 3.00170623 |
| 37 | desmosome organization (GO:0002934) | 2.97786467 |
| 38 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.93562685 |
| 39 | regulation of fatty acid oxidation (GO:0046320) | 2.92974455 |
| 40 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.92381896 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.92177639 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 2.92177639 |
| 43 | maternal placenta development (GO:0001893) | 2.90688911 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 2.90545825 |
| 45 | viral transcription (GO:0019083) | 2.89386108 |
| 46 | activation of Rac GTPase activity (GO:0032863) | 2.87544604 |
| 47 | adenine nucleotide transport (GO:0051503) | 2.85579877 |
| 48 | positive regulation of histone deacetylation (GO:0031065) | 2.84594624 |
| 49 | folic acid metabolic process (GO:0046655) | 2.82823383 |
| 50 | atrioventricular valve morphogenesis (GO:0003181) | 2.82350903 |
| 51 | glycosphingolipid catabolic process (GO:0046479) | 2.80629261 |
| 52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.79505455 |
| 53 | glutathione biosynthetic process (GO:0006750) | 2.79401477 |
| 54 | adherens junction assembly (GO:0034333) | 2.75786384 |
| 55 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.74590549 |
| 56 | cell-substrate adherens junction assembly (GO:0007045) | 2.72643265 |
| 57 | focal adhesion assembly (GO:0048041) | 2.72643265 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.67512743 |
| 59 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.67512743 |
| 60 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.65651443 |
| 61 | purine ribonucleotide transport (GO:0015868) | 2.64729042 |
| 62 | purine nucleotide transport (GO:0015865) | 2.61062307 |
| 63 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.60936229 |
| 64 | response to food (GO:0032094) | 2.60273787 |
| 65 | oligosaccharide catabolic process (GO:0009313) | 2.58983087 |
| 66 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57738028 |
| 67 | endocytic recycling (GO:0032456) | 2.57275183 |
| 68 | modulation by virus of host process (GO:0019054) | 2.56756945 |
| 69 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.55913345 |
| 70 | basement membrane organization (GO:0071711) | 2.54816768 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 2.52489734 |
| 72 | positive regulation of fatty acid oxidation (GO:0046321) | 2.52434250 |
| 73 | low-density lipoprotein particle clearance (GO:0034383) | 2.50739465 |
| 74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.50697775 |
| 75 | glucose catabolic process (GO:0006007) | 2.50506883 |
| 76 | COPI coating of Golgi vesicle (GO:0048205) | 2.50033387 |
| 77 | Golgi transport vesicle coating (GO:0048200) | 2.50033387 |
| 78 | translational termination (GO:0006415) | 2.49724646 |
| 79 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.47762806 |
| 80 | mammary gland epithelial cell differentiation (GO:0060644) | 2.47061615 |
| 81 | glycolipid catabolic process (GO:0019377) | 2.46266722 |
| 82 | cell junction maintenance (GO:0034331) | 2.44264281 |
| 83 | tooth mineralization (GO:0034505) | 2.43824029 |
| 84 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.43471091 |
| 85 | negative regulation of viral release from host cell (GO:1902187) | 2.43411576 |
| 86 | regulation of translational fidelity (GO:0006450) | 2.42774995 |
| 87 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42208859 |
| 88 | regulation of extracellular matrix disassembly (GO:0010715) | 2.41909342 |
| 89 | negative regulation of catenin import into nucleus (GO:0035414) | 2.41629276 |
| 90 | modulation by symbiont of host cellular process (GO:0044068) | 2.41409966 |
| 91 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.40754555 |
| 92 | diaphragm development (GO:0060539) | 2.39755746 |
| 93 | response to misfolded protein (GO:0051788) | 2.39348054 |
| 94 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.38150831 |
| 95 | establishment of apical/basal cell polarity (GO:0035089) | 2.37953400 |
| 96 | translational elongation (GO:0006414) | 2.37468838 |
| 97 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.36824945 |
| 98 | oxaloacetate metabolic process (GO:0006107) | 2.34840473 |
| 99 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.34814790 |
| 100 | actin filament bundle organization (GO:0061572) | 2.33982015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.26216297 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.08930861 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.06995531 |
| 4 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.66783851 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61590206 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57824844 |
| 7 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.56299473 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.26705227 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.25048799 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18813884 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.18494385 |
| 12 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.16533054 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.14188966 |
| 14 | P68_20966046_ChIP-Seq_HELA_Human | 2.11697589 |
| 15 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.09296499 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03717610 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03249935 |
| 18 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.00113556 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86912094 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85777506 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.81011517 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.77331643 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75903831 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.72731375 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.72119115 |
| 26 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.65721733 |
| 27 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.64821463 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.60294234 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59700208 |
| 30 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59075335 |
| 31 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58912645 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58551595 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58385651 |
| 34 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.55556448 |
| 35 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.54359503 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54053520 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53630621 |
| 38 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.52698275 |
| 39 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.52379823 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.52219298 |
| 41 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.51627781 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48621696 |
| 43 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.47902127 |
| 44 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.47703118 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47087513 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46435324 |
| 47 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43730120 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.42836395 |
| 49 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.41836744 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41792945 |
| 51 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40611751 |
| 52 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.40458019 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39028474 |
| 54 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38988210 |
| 55 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.37276372 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35109393 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.33803567 |
| 58 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.31010707 |
| 59 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.30930142 |
| 60 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.30825548 |
| 61 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.29226179 |
| 62 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.28476360 |
| 63 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.27876517 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.26184683 |
| 65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26108674 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24289660 |
| 67 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.21518737 |
| 68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20389476 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19825731 |
| 70 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.18884133 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17928411 |
| 72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16761532 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14418768 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14291852 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.14078722 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13309330 |
| 77 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12462979 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12161894 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10853113 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10547356 |
| 81 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10255804 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09241425 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08801473 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07611614 |
| 85 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07276993 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06840203 |
| 87 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06835134 |
| 88 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05751302 |
| 89 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05032961 |
| 90 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04254819 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03935149 |
| 92 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03225847 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03081202 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02685593 |
| 95 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.02641299 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02566246 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02510400 |
| 98 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.02178216 |
| 99 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01623529 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01572352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.66556325 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.63863818 |
| 3 | MP0009840_abnormal_foam_cell | 3.22811634 |
| 4 | MP0005451_abnormal_body_composition | 2.94862208 |
| 5 | MP0005409_darkened_coat_color | 2.82830605 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.69720404 |
| 7 | MP0005076_abnormal_cell_differentiation | 2.66291615 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 2.64914949 |
| 9 | MP0005360_urolithiasis | 2.49253343 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.47114094 |
| 11 | MP0003453_abnormal_keratinocyte_physiol | 2.40873671 |
| 12 | MP0000751_myopathy | 2.23197781 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.20585620 |
| 14 | MP0005501_abnormal_skin_physiology | 2.16292377 |
| 15 | MP0000678_abnormal_parathyroid_gland | 2.13675712 |
| 16 | MP0002249_abnormal_larynx_morphology | 2.10893631 |
| 17 | MP0005171_absent_coat_pigmentation | 2.10315161 |
| 18 | MP0004858_abnormal_nervous_system | 2.03383378 |
| 19 | MP0005083_abnormal_biliary_tract | 2.01407475 |
| 20 | MP0005666_abnormal_adipose_tissue | 1.97828928 |
| 21 | MP0003123_paternal_imprinting | 1.93696799 |
| 22 | MP0005670_abnormal_white_adipose | 1.91639140 |
| 23 | MP0000003_abnormal_adipose_tissue | 1.82736231 |
| 24 | MP0002796_impaired_skin_barrier | 1.81867233 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.73923624 |
| 26 | MP0005174_abnormal_tail_pigmentation | 1.73870637 |
| 27 | MP0005375_adipose_tissue_phenotype | 1.73468150 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.72965615 |
| 29 | MP0005365_abnormal_bile_salt | 1.71368320 |
| 30 | MP0001849_ear_inflammation | 1.70808280 |
| 31 | MP0001661_extended_life_span | 1.65110897 |
| 32 | MP0000747_muscle_weakness | 1.53045144 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.47843028 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.47738517 |
| 35 | MP0005330_cardiomyopathy | 1.46518905 |
| 36 | MP0004130_abnormal_muscle_cell | 1.40639895 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.40248575 |
| 38 | MP0000538_abnormal_urinary_bladder | 1.35495186 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.32956380 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.30497688 |
| 41 | MP0005332_abnormal_amino_acid | 1.29096689 |
| 42 | MP0001756_abnormal_urination | 1.29065927 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.27375676 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.23636822 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.22326245 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.22211802 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21590827 |
| 48 | MP0003879_abnormal_hair_cell | 1.21537569 |
| 49 | MP0004510_myositis | 1.11507504 |
| 50 | MP0001188_hyperpigmentation | 1.11340052 |
| 51 | MP0004381_abnormal_hair_follicle | 1.10142730 |
| 52 | MP0003279_aneurysm | 1.09241886 |
| 53 | MP0001664_abnormal_digestion | 1.08624762 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 1.05776332 |
| 55 | MP0001873_stomach_inflammation | 1.05210495 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.04552460 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.03984897 |
| 58 | MP0002060_abnormal_skin_morphology | 0.99258116 |
| 59 | MP0009931_abnormal_skin_appearance | 0.98754163 |
| 60 | MP0009643_abnormal_urine_homeostasis | 0.95844077 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 0.95544216 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 0.95253709 |
| 63 | MP0000462_abnormal_digestive_system | 0.94473213 |
| 64 | MP0004233_abnormal_muscle_weight | 0.92441657 |
| 65 | MP0000470_abnormal_stomach_morphology | 0.88689549 |
| 66 | MP0001348_abnormal_lacrimal_gland | 0.87292564 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 0.86306991 |
| 68 | MP0009053_abnormal_anal_canal | 0.83252808 |
| 69 | MP0003136_yellow_coat_color | 0.83126670 |
| 70 | MP0001502_abnormal_circadian_rhythm | 0.82914138 |
| 71 | MP0001216_abnormal_epidermal_layer | 0.82662708 |
| 72 | MP0008438_abnormal_cutaneous_collagen | 0.82326808 |
| 73 | MP0009278_abnormal_bone_marrow | 0.81474804 |
| 74 | MP0002970_abnormal_white_adipose | 0.81368033 |
| 75 | MP0000566_synostosis | 0.81341479 |
| 76 | MP0000759_abnormal_skeletal_muscle | 0.80608288 |
| 77 | MP0010329_abnormal_lipoprotein_level | 0.80570491 |
| 78 | MP0003566_abnormal_cell_adhesion | 0.80126397 |
| 79 | MP0000609_abnormal_liver_physiology | 0.79802677 |
| 80 | MP0010771_integument_phenotype | 0.79559723 |
| 81 | MP0004087_abnormal_muscle_fiber | 0.77981193 |
| 82 | MP0000467_abnormal_esophagus_morphology | 0.77081309 |
| 83 | MP0008260_abnormal_autophagy | 0.76575448 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76292333 |
| 85 | MP0003942_abnormal_urinary_system | 0.75293660 |
| 86 | MP0000377_abnormal_hair_follicle | 0.74698113 |
| 87 | MP0003091_abnormal_cell_migration | 0.74603306 |
| 88 | MP0002254_reproductive_system_inflammat | 0.74251887 |
| 89 | MP0002971_abnormal_brown_adipose | 0.73198566 |
| 90 | MP0000858_altered_metastatic_potential | 0.73055654 |
| 91 | MP0003303_peritoneal_inflammation | 0.71536412 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.70980730 |
| 93 | MP0001958_emphysema | 0.68931340 |
| 94 | MP0000733_abnormal_muscle_development | 0.67929778 |
| 95 | MP0003329_amyloid_beta_deposits | 0.67850684 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.66987082 |
| 97 | MP0000477_abnormal_intestine_morphology | 0.66301294 |
| 98 | MP0000681_abnormal_thyroid_gland | 0.65054077 |
| 99 | MP0000534_abnormal_ureter_morphology | 0.64685356 |
| 100 | MP0000367_abnormal_coat/_hair | 0.64219858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Testicular atrophy (HP:0000029) | 4.46997704 |
| 2 | Thin bony cortex (HP:0002753) | 4.24926654 |
| 3 | Ulnar bowing (HP:0003031) | 4.15762639 |
| 4 | Hemorrhage of the eye (HP:0011885) | 3.42760353 |
| 5 | Turricephaly (HP:0000262) | 3.35418717 |
| 6 | Vaginal fistula (HP:0004320) | 2.92862008 |
| 7 | Myopathic facies (HP:0002058) | 2.85665381 |
| 8 | Hyperacusis (HP:0010780) | 2.61214539 |
| 9 | Distal lower limb muscle weakness (HP:0009053) | 2.59329580 |
| 10 | Rib fusion (HP:0000902) | 2.58927555 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.53893081 |
| 12 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.53893081 |
| 13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.53893081 |
| 14 | Bowed forearm bones (HP:0003956) | 2.53025792 |
| 15 | Bowing of the arm (HP:0006488) | 2.53025792 |
| 16 | Cervical subluxation (HP:0003308) | 2.52023219 |
| 17 | Achilles tendon contracture (HP:0001771) | 2.48374203 |
| 18 | Delayed epiphyseal ossification (HP:0002663) | 2.47469598 |
| 19 | Hyperparathyroidism (HP:0000843) | 2.45921047 |
| 20 | Mucopolysacchariduria (HP:0008155) | 2.45618000 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45618000 |
| 22 | Rectovaginal fistula (HP:0000143) | 2.45003488 |
| 23 | Rectal fistula (HP:0100590) | 2.45003488 |
| 24 | Intestinal fistula (HP:0100819) | 2.44313319 |
| 25 | Joint stiffness (HP:0001387) | 2.42565088 |
| 26 | Deep venous thrombosis (HP:0002625) | 2.38499569 |
| 27 | Coronal craniosynostosis (HP:0004440) | 2.38340710 |
| 28 | Prolonged partial thromboplastin time (HP:0003645) | 2.36543101 |
| 29 | Abnormality of the Achilles tendon (HP:0005109) | 2.36503562 |
| 30 | Annular pancreas (HP:0001734) | 2.36249944 |
| 31 | Stridor (HP:0010307) | 2.35147150 |
| 32 | Mesangial abnormality (HP:0001966) | 2.28030936 |
| 33 | Easy fatigability (HP:0003388) | 2.23313139 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.19009880 |
| 35 | Poikiloderma (HP:0001029) | 2.18206732 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 2.17608166 |
| 37 | Aplasia of the musculature (HP:0100854) | 2.17022222 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16327833 |
| 39 | Bulbar palsy (HP:0001283) | 2.15622151 |
| 40 | Hyperthyroidism (HP:0000836) | 2.12363565 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11695767 |
| 42 | Broad distal phalanx of finger (HP:0009836) | 2.10652545 |
| 43 | J-shaped sella turcica (HP:0002680) | 2.08900435 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.07171394 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.06256109 |
| 46 | Abnormality of the thoracic spine (HP:0100711) | 2.05805648 |
| 47 | Neonatal onset (HP:0003623) | 2.05443132 |
| 48 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.04184660 |
| 49 | Joint hemorrhage (HP:0005261) | 2.03507858 |
| 50 | Choanal stenosis (HP:0000452) | 2.02866924 |
| 51 | Thin ribs (HP:0000883) | 2.01790711 |
| 52 | Squamous cell carcinoma (HP:0002860) | 2.01366585 |
| 53 | Xanthomatosis (HP:0000991) | 2.00917798 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.00748928 |
| 55 | Progressive muscle weakness (HP:0003323) | 1.97069376 |
| 56 | Increased muscle lipid content (HP:0009058) | 1.96184293 |
| 57 | Congenital glaucoma (HP:0001087) | 1.93072305 |
| 58 | Abdominal distention (HP:0003270) | 1.92944488 |
| 59 | Broad face (HP:0000283) | 1.92475242 |
| 60 | Generalized amyotrophy (HP:0003700) | 1.91284087 |
| 61 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.90714461 |
| 62 | Protrusio acetabuli (HP:0003179) | 1.88952268 |
| 63 | Obstructive sleep apnea (HP:0002870) | 1.88795009 |
| 64 | Slender long bone (HP:0003100) | 1.87947756 |
| 65 | Asymmetry of the thorax (HP:0001555) | 1.87484762 |
| 66 | Disproportionate tall stature (HP:0001519) | 1.86693786 |
| 67 | Hypophosphatemia (HP:0002148) | 1.85280292 |
| 68 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83373463 |
| 69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83296860 |
| 70 | Flat acetabular roof (HP:0003180) | 1.82767039 |
| 71 | Upper limb amyotrophy (HP:0009129) | 1.81912930 |
| 72 | Distal upper limb amyotrophy (HP:0007149) | 1.81912930 |
| 73 | Lymphangioma (HP:0100764) | 1.81524552 |
| 74 | Anteriorly placed anus (HP:0001545) | 1.81433744 |
| 75 | Fragile skin (HP:0001030) | 1.79179784 |
| 76 | Abnormal urine phosphate concentration (HP:0012599) | 1.79076209 |
| 77 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.78839229 |
| 78 | Facial hemangioma (HP:0000329) | 1.78250681 |
| 79 | Increased connective tissue (HP:0009025) | 1.78025600 |
| 80 | Malnutrition (HP:0004395) | 1.76612465 |
| 81 | Short nail (HP:0001799) | 1.75758190 |
| 82 | Long palpebral fissure (HP:0000637) | 1.74465437 |
| 83 | Rectal prolapse (HP:0002035) | 1.74169787 |
| 84 | Abnormality of complement system (HP:0005339) | 1.73921057 |
| 85 | Atrioventricular block (HP:0001678) | 1.73770875 |
| 86 | Akinesia (HP:0002304) | 1.72556645 |
| 87 | Germ cell neoplasia (HP:0100728) | 1.70649814 |
| 88 | Thoracic kyphosis (HP:0002942) | 1.68927211 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 1.68452749 |
| 90 | Reticulocytosis (HP:0001923) | 1.68074142 |
| 91 | Abnormal number of erythroid precursors (HP:0012131) | 1.67747645 |
| 92 | Increased serum ferritin (HP:0003281) | 1.67660053 |
| 93 | Hypertriglyceridemia (HP:0002155) | 1.67531973 |
| 94 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.66872442 |
| 95 | Bone pain (HP:0002653) | 1.65205295 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.65019005 |
| 97 | Genu recurvatum (HP:0002816) | 1.64587314 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 1.64448061 |
| 99 | Hypercortisolism (HP:0001578) | 1.64275978 |
| 100 | Cerebral aneurysm (HP:0004944) | 1.64259783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.74278224 |
| 2 | SIK1 | 4.11909555 |
| 3 | NME2 | 3.25100442 |
| 4 | EPHA2 | 3.22176206 |
| 5 | IRAK3 | 3.14332094 |
| 6 | SMG1 | 3.08220572 |
| 7 | ERN1 | 2.90422176 |
| 8 | ICK | 2.78473080 |
| 9 | MAPK15 | 2.47743058 |
| 10 | PKN2 | 2.42713482 |
| 11 | EEF2K | 2.37956491 |
| 12 | PRPF4B | 2.02117830 |
| 13 | TESK2 | 1.91727607 |
| 14 | PRKD3 | 1.83465739 |
| 15 | TLK1 | 1.75245436 |
| 16 | MAP3K11 | 1.71294450 |
| 17 | MAP2K3 | 1.69976811 |
| 18 | MST1R | 1.68415351 |
| 19 | RIPK1 | 1.64957798 |
| 20 | TTN | 1.46488063 |
| 21 | PRKD2 | 1.40106256 |
| 22 | MUSK | 1.39979403 |
| 23 | TESK1 | 1.35993720 |
| 24 | MAPKAPK3 | 1.28517969 |
| 25 | MAP3K10 | 1.28247326 |
| 26 | PTK6 | 1.28165649 |
| 27 | RPS6KB2 | 1.26105137 |
| 28 | IRAK2 | 1.20974897 |
| 29 | PDPK1 | 1.17379430 |
| 30 | TAOK1 | 1.14861812 |
| 31 | MTOR | 1.09251020 |
| 32 | PIM2 | 1.06750396 |
| 33 | PAK4 | 1.05578657 |
| 34 | TAOK2 | 1.04482415 |
| 35 | FGFR4 | 1.04289951 |
| 36 | RPS6KA2 | 1.02969340 |
| 37 | LMTK2 | 1.01175177 |
| 38 | ARAF | 0.95403799 |
| 39 | SIK2 | 0.94869991 |
| 40 | ILK | 0.94741341 |
| 41 | PTK2 | 0.94466888 |
| 42 | EPHB2 | 0.93356577 |
| 43 | MAP2K2 | 0.89377455 |
| 44 | MAP3K3 | 0.86029161 |
| 45 | RPS6KC1 | 0.84204355 |
| 46 | RPS6KL1 | 0.84204355 |
| 47 | ABL2 | 0.82693610 |
| 48 | CDC42BPA | 0.79578429 |
| 49 | GRK6 | 0.77603654 |
| 50 | BRAF | 0.76720797 |
| 51 | TBK1 | 0.73778640 |
| 52 | BMX | 0.73552450 |
| 53 | MARK2 | 0.73292526 |
| 54 | MAP3K1 | 0.73012880 |
| 55 | DDR2 | 0.70614509 |
| 56 | MAPK11 | 0.69027615 |
| 57 | LRRK2 | 0.68493783 |
| 58 | DMPK | 0.66266156 |
| 59 | STK16 | 0.65435461 |
| 60 | TNK2 | 0.64892568 |
| 61 | RPS6KA6 | 0.64338628 |
| 62 | AURKA | 0.64176919 |
| 63 | HIPK2 | 0.60518469 |
| 64 | PRKG2 | 0.59523090 |
| 65 | PRKCI | 0.59194749 |
| 66 | MAP2K6 | 0.58411805 |
| 67 | CDK4 | 0.58357322 |
| 68 | BLK | 0.57560014 |
| 69 | DYRK1B | 0.55150672 |
| 70 | CDK12 | 0.55066081 |
| 71 | PDGFRA | 0.54283854 |
| 72 | MAP3K6 | 0.53998190 |
| 73 | WNK4 | 0.53449114 |
| 74 | CAMK1D | 0.51271589 |
| 75 | IRAK4 | 0.50552035 |
| 76 | STK38 | 0.50155824 |
| 77 | DAPK3 | 0.48439290 |
| 78 | MAPK12 | 0.46907954 |
| 79 | PHKG2 | 0.46029014 |
| 80 | PHKG1 | 0.46029014 |
| 81 | NEK2 | 0.45973200 |
| 82 | AKT2 | 0.45012163 |
| 83 | PRKD1 | 0.44627268 |
| 84 | CHUK | 0.42418421 |
| 85 | CDK7 | 0.42050074 |
| 86 | VRK2 | 0.40396103 |
| 87 | MET | 0.40217896 |
| 88 | BCKDK | 0.39637569 |
| 89 | MAP3K8 | 0.38711339 |
| 90 | STK4 | 0.37321599 |
| 91 | CAMK2G | 0.35939622 |
| 92 | TYRO3 | 0.35937898 |
| 93 | MAP4K1 | 0.35352510 |
| 94 | RPS6KA1 | 0.35228018 |
| 95 | PDK1 | 0.31850050 |
| 96 | PAK1 | 0.29591615 |
| 97 | MAP3K9 | 0.29455424 |
| 98 | MAP2K4 | 0.29338809 |
| 99 | MELK | 0.28649340 |
| 100 | MAPK4 | 0.27004226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 5.33341701 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.33502575 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.27389346 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.75265778 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.43583516 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.41937282 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.34999510 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.23965303 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.16715630 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84132496 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.81029341 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.77320704 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 1.73938248 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73229529 |
| 15 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.64343343 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61461321 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.59479494 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.57897862 |
| 19 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39905416 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38766156 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.37829685 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.35949811 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32962248 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.26772211 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24248433 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23363529 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.18409490 |
| 28 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16758664 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15733498 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12064573 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09443518 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09332003 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.08541895 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07692781 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06823465 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.05560062 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05291167 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02242311 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00832921 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99232550 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94215919 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92869141 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89807309 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88124374 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87664800 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87510802 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85828349 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81751915 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.81198153 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81121589 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80814457 |
| 52 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78993725 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78545753 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.74608892 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73927047 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73561789 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71044754 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.70039778 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 0.69262902 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68884480 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68549021 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66494980 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65237507 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64664677 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63660987 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63454219 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62270391 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61221933 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59202186 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58612606 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55811211 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55274083 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53395769 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50898621 |
| 75 | Base excision repair_Homo sapiens_hsa03410 | 0.50756348 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48217677 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46195006 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45988138 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45940218 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44858891 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44518942 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42248574 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41725158 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.38788447 |
| 85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38081397 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.38038994 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37655401 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37608225 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37522996 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37455448 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35724080 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34999723 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32864188 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32454731 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32273037 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31692853 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31085694 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.30513607 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30263079 |
| 100 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.28551020 |

